Biotechnology

Healthcare 'covid-19 bubble' reminiscent of dotcom boom, fund managers warn

• Health Insurance
• 02 June 2020

Biotech: Breathing space before next growth curve

• Alternative
• 12 August 2016

Sectoral AM launches new biotech fund

• Alternative
• 09 June 2016

Candriam expands biotech team

• Alternative
• 07 April 2016

Candriam appoints senior biotech analyst

• Alternative
• 10 December 2015

Biotech volatility offers opportunities

• Alternative
• 23 September 2015

Biotech volatility offers opportunities

• Comment
• 23 September 2015

Biotechnologie - Chancen, Risiken und Nebenwirkungen

• Alternative
• 17 July 2015

Solactive launches Pharma & Biotech Opportunities Index

• Platforms
• 13 May 2015

Solactive launches Pharma & Biotech Opportunities Index

• Alternative
• 13 May 2015

Biotech : there is more to come

• Alternative
• 24 April 2015

Biotech : there is more to come

• Comment
• 24 April 2015

Long-term investors to benefit from biotech sector

• Alternative
• 17 April 2015

Long-term investors to benefit from biotech sector

• Platforms
• 17 April 2015

Swedbank Robur varnar för bioteknikpatent som löper ut

• Platforms
• 15 April 2015

Swedbank Robur varnar för bioteknikpatent som löper ut

• Alternative
• 15 April 2015

Nordic portfolio key holding expected to rise 20% at JP Morgan

• Platforms
• 05 January 2015

Nordic portfolio key holding expected to rise 20% at JP Morgan

• Alternative
• 05 January 2015

Source launches biotech ETF for Europe

• Alternative
• 10 November 2014

Biotechnology will be the sector of choice for investors

• Alternative
• 03 November 2014